Alambic Investment Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Alambic Investment Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-11,320	Closed	-$59K	–	730
2016 Q4	$59K	Sell	11,320 -1,800	-14%	-$8.46K	0.01%	552
2016 Q3	$61K	Sell	13,120 -14,500	-52%	-$67.7K	0.01%	494
2016 Q2	$109K	Sell	27,620 -21,415	-44%	-$80K	0.03%	494
2016 Q1	$152K	Buy	49,035 +20,435	+71%	+$68.5K	0.05%	421
2015 Q4	$131K	Buy	+28,600	New	+$136K	0.08%	318

Other funds holding DSCI

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Alambic Investment Management's DSCI Position: Q1 2017 in Review

Alambic Investment Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 11,320 shares — an estimated $59K sold.

Alambic Investment Management first reported a position in DSCI in Q4 2015 and held it in 5 quarters. The position peaked at $152K in Q1 2016. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

Alambic Investment Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
Alambic Investment Management sold 11,320 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $59K.
Alambic Investment Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q4 2015 and held it in 5 quarters.
Alambic Investment Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $152K in Q1 2016.
1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Alambic Investment Management's 13F filing for Q1 2017, filed 9 May 2017.